Capecitabine vs. S-1 in Unresectable or Recurrent Breast Cancer

Clinical trial NCT00438100 · COMPLETED

Trial details

NCT number: NCT00438100
Sponsor: Japan Breast Cancer Research Network
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2008-04-01
Primary completion: 2012-07-01
Enrollment: 142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.